DKK1 and plasma cell myeloma: In xenograft models of cancers that include multiple myeloma (MM), osteosarcoma, HCC, lung, and prostate cancers, neutralization or inhibition of DKK1 has been successful in inhibiting tumour growth in some cases or tumours burden in others [66,79,80,81].